Women’s Health Innovators Session | MaRS Impact Health 2023

Published on July 24, 2023

The post Women’s Health Innovators Session | MaRS Impact Health 2023 appeared first on MaRS Discovery District.

Continue reading on website
Other news

InMed to Participate in Fireside Chat with Water Tower Research on July 25, 2023 at 2pm ET

July 21, 2023
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announce Jerry Griffin, VP of Sales and Marketing for InMed’s subsidiary BayMedica LLC (“BayMedica”), a leading supplier of bioidentical rare cannabinoids to the Health and

Roche signs onto Alnylam’s mid-stage hypertension med for $310 million upfront

July 24, 2023
Roche is hitching its wagon to Alnylam’s mid-stage hypertension med, zilebesiran, and coughing up $310 million in upfront cash for the journey.The new partnership gives the Swiss pharma full ex-U.S. rights to the drug and co-U.S. rights alongside Alnylam, in exchange for the $310 million plus up to $2.8 billion in potential milestone payments. The two companies will co-commercialize and split prof